Blackstone buys stake in Chinese implant maker

The US private equity firm has invested in China’s fast-growing medical device sector, buying a stake Jiangsu-based Xinrong.

Alison Tudor-Ackroyd

September 23, 2014

Blackstone has agreed to make a significant investment into Xinrong Best Medical Instrument, a Chinese maker of orthopaedic implants for trauma, spine and joint applications.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

M&A
North Asia

#china
#private equity
#acquisitions